Seer (SEER) Revenue (2020 - 2026)

Seer (SEER) recorded quarterly Revenue of $2.8 million in Q1 2026, down 33.52% quarter-over-quarter from $4.2 million in Q4 2025, and down 33.58% on a YoY basis from $4.2 million in Q1 2025.

Seer (SEER) Revenue (2020 - 2026) Analysis & Trends

Seer's Revenue history runs 7 years deep, the most recent figure standing at $2.8 million for Q1 2026.

  • In Q1 2026, Revenue fell 33.58% year-over-year to $2.8 million; the TTM figure through Mar 2026 stood at $15.2 million (down 0.93% YoY), while the FY2025 annual figure was $16.6 million, up 16.99% from the prior year.
  • Revenue was $2.8 million for Q1 2026 at Seer, down from $4.2 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $4.6 million in Q4 2022 to a low of $2.8 million in Q1 2026.
  • Historically, Revenue has averaged $3.9 million across 5 years, with a median of $4.0 million in 2024.
  • The sharpest annual moves came in 2022 and 2026: Revenue soared 5241.94% in 2022, then sank 33.58% in 2026.
  • A 5-year view of Revenue shows it stood at $4.6 million in 2022, then decreased by 3.63% to $4.4 million in 2023, then dropped by 9.87% to $4.0 million in 2024, then gained by 5.03% to $4.2 million in 2025, then tumbled by 33.52% to $2.8 million in 2026.
  • The last three Revenue figures came in at $2.8 million (Q1 2026), $4.2 million (Q4 2025), and $4.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - 5.21 Mn
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 306.30 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 2.99 Bn
9 Abivax 94.37 Bn 94.37 Bn - -
10 Seer 99.67 Mn 99.67 Mn 982,000.00 2.79 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.79 Mn
Dec 31, 2025 4.20 Mn
Sep 30, 2025 4.12 Mn
Jun 30, 2025 4.05 Mn
Mar 31, 2025 4.21 Mn
Dec 31, 2024 4.00 Mn
Sep 30, 2024 4.03 Mn
Jun 30, 2024 3.07 Mn
Mar 31, 2024 3.07 Mn
Dec 31, 2023 4.44 Mn
Sep 30, 2023 4.16 Mn
Jun 30, 2023 4.01 Mn
Mar 31, 2023 4.05 Mn
Dec 31, 2022 4.61 Mn
Sep 30, 2022 3.96 Mn
Jun 30, 2022 3.62 Mn
Mar 31, 2022 3.31 Mn
Dec 31, 2021 3.07 Mn
Sep 30, 2021 2.16 Mn
Jun 30, 2021 1.33 Mn